Navigation Links
Nanotechnology Could Treat Spinal Cord Injuries, Diabetes, and Parkinson's Disease

Dr. Samuel I. Stupp has combined nanotechnology and biology to enable the body to heal itself and has achieved amazing early results. Dr. Samuel is the director of the Institute// of BioNanotechnology in Medicine at Northwestern University. He suggests that nanotechnology can be used to mobilize the body’s own healing abilities to repair or regenerate damaged cells.

In a dramatic demonstration of what nanotechnology might achieve in regenerative medicine, paralyzed lab mice with spinal cord injuries have regained the ability to walk using their hind limbs six weeks after a simple injection of a purpose-designed nanomaterial.

"By injecting molecules that were designed to self-assemble into nanostructures in the spinal tissue, we have been able to rescue and regrow rapidly damaged neurons," said Dr. Stupp at an April 23 session hosted by the Project on Emerging Nanotechnologies. "The nanofibers – thousands of times thinner than a human hair – are the key to not only preventing the formation of harmful scar tissue which inhibits spinal cord healing, but to stimulating the body into regenerating lost or damaged cells."

Stupp’s work hinges on a fundamental area of nanotechnology – self-assembly – that someday should enable medical researchers to tailor and deliver individualized patient treatments in previously unimaginable ways. Stupp and his coworkers designed molecules with the capacity to self-assemble into nanofibers once injected into the body with a syringe. When the nanofibers form they can be immobilized in an area of tissue where it is necessary to activate some biological process, for example saving damaged cells or regenerating needed differentiated cells from stem cells.

This same work also has implications for Parkinson’s and Alzheimer’s, both diseases in which key brain cells stop working properly.

During his presentation, Dr. Stupp allowed a rare glimpse into ongoing research with collaborator
'"/>




Page: 1 2

Related medicine news :

1. CoQ10 bioavailability increased by Nanotechnology
2. Nanotechnology Revolution To Be Spearheaded By European Union
3. RNA Nanotechnology To Rescue Cancer Patients In Future
4. Scientists Consider About New Technology Called Nanotechnology
5. Potential Benefits Of New Nanotechnology
6. Nanotechnology Promises Huge Medical Benefits
7. Nanotechnology at its best: Nanomotors And Mechanical Nanoswitches
8. Nanotechnology Could Revolutionize Cardiac Treatment
9. Anti-Sense Drugs and Nanotechnology Offer New Hope In Cancer Fight
10. Nanotechnology – to detect and treat ovarian cance
11. Nanotechnology Used For Detecting Viruses
Post Your Comments:
Other Medicine News:Health News:New Jersey Hospitals Post Razor Thin 0.6 Percent Operating Margin for 2006, Down 1 Percent from 2005 2Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 2Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 3Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 4Health News:FDA Mulls Cutting Salt in Processed Foods 2Health News:FDA Mulls Cutting Salt in Processed Foods 3Health News:FDA Mulls Cutting Salt in Processed Foods 4Health News:STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference 2Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 2Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 3Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 4Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 5Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 6Health News:Out of hours doctors reluctant to do home visits, say patients 2